These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease. Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493 [TBL] [Abstract][Full Text] [Related]
6. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP. Leedman PJ; Frauman AG; Colman PG; Michelangeli VP Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083 [TBL] [Abstract][Full Text] [Related]
7. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. Orgiazzi J; Williams DE; Chopra IJ; Solomon DH J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604 [TBL] [Abstract][Full Text] [Related]
8. [The effects of TSH, cholera toxin and Graves' IgG on cAMP production in cultured human thyroid adenoma cells in monolayer]. Tsuboi K Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):541-53. PubMed ID: 2862066 [TBL] [Abstract][Full Text] [Related]
9. Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody. Zakarija M; McKenzie JM Endocrinology; 1980 Dec; 107(6):2051-4. PubMed ID: 6107244 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of thyroid hormone and thyrotropin on iodothyronine 5'-deiodinase in FRTL-5 rat thyroid cells. Toyoda N; Nishikawa M; Horimoto M; Yoshikawa N; Mori Y; Yoshimura M; Masaki H; Tanaka K; Inada M Endocrinology; 1990 Sep; 127(3):1199-205. PubMed ID: 2167209 [TBL] [Abstract][Full Text] [Related]
12. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468 [TBL] [Abstract][Full Text] [Related]
14. Activity of thyroid stimulating antibody and thyroid stimulation blocking antibody determined by radioiodine uptake into FRTL-5 cells. Yoshikawa N; Nishikawa M; Horimoto M; Uno C; Taniguchi N; Inada M Endocrinol Jpn; 1989 Feb; 36(1):55-63. PubMed ID: 2567231 [TBL] [Abstract][Full Text] [Related]
15. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies. Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of TSH-binding inhibitor immunoglobulin and thyroid stimulating autoantibody activities using cultured FRTL-5 cells in patients with untreated Graves' disease. Lu C; Kasagi K; Hidaka A; Hatabu H; Iida Y; Konishi J Acta Endocrinol (Copenh); 1990 Sep; 123(3):282-90. PubMed ID: 1978457 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulins from Graves' disease patients stimulate phospholipase A2 and C systems in FRTL-5 and human thyroid cells. Atwa MA; Smallridge RC; Burch HB; Gist ID; Lu R; Abo-Hashem EM; el-Kannishy MH; Burman KD Eur J Endocrinol; 1996 Sep; 135(3):322-7. PubMed ID: 8890723 [TBL] [Abstract][Full Text] [Related]
18. Thyroglobulin release-stimulating activity in immunoglobulin G from patients with Graves' disease studied by human thyroid cells in vitro. Fukue Y; Uchimura H; Mitsuhashi T; Okano S; Kanaji Y; Takaku F J Clin Endocrinol Metab; 1987 Feb; 64(2):261-5. PubMed ID: 2878936 [TBL] [Abstract][Full Text] [Related]
19. Effects of fibroblast growth factor on type I 5'-deiodinase in FRTL-5 rat thyroid cells. Tang KT; Braverman LE; DeVito WJ Endocrinology; 1994 Aug; 135(2):493-500. PubMed ID: 7518381 [TBL] [Abstract][Full Text] [Related]
20. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]